Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
Authors:
- Adriana Linares BallesterosABAdriana Linares Ballesteros
- Roy Sanguino LoboRLRoy Sanguino Lobo
- Juan Camilo Villada ValenciaJVJuan Camilo Villada Valencia
- Oscar Arévalo LealOLOscar Arévalo Leal
- Diana Constanza Plazas HernándezDHDiana Constanza Plazas Hernández
- Nelson Aponte BarriosNBNelson Aponte Barrios
- Iván Perdomo RamírezIRIván Perdomo Ramírez
Open Access
- 30 January 2021
- journal article
- research article
- Published by Universidad del Valle in Colombia Medica
- Vol. 52 (1) , e2034542
Abstract
Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity. Objective: To describe the incidence of early-onset cardiotoxicity in children with acute leukemia treated with chemotherapy. Methods: A prospective descriptive study of patients >1 y and 150 mg/m2, between the first echocardiographic evaluation and posterior analyses in the left ventricular fraction ejection with Teicholz p 0.05, Simpson p 0.018 and GLS p 0.004. In this study, there was no relation between blood biomarkers and cardiotoxicity. Conclusions: Cancer therapeutic-related cardiac dysfunction is related to anthracycline cumulative dose. In this study, echocardiographic follow-up was useful to predict risk factors for early cardiac dysfunction.Keywords
This publication has 40 references indexed in Scilit:
- The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivorsAnnals of Oncology, 2012
- Torsion analysis in the early detection of anthracycline-mediated cardiomyopathyEuropean Heart Journal - Cardiovascular Imaging, 2011
- Myocardial Strain and Strain Rate in Monitoring Subclinical Heart Failure in Asymptomatic Long-Term Survivors of Childhood CancerUltrasound in Medicine & Biology, 2010
- Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood CancerJournal of Clinical Oncology, 2010
- Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme InhibitionCirculation, 2006
- Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2005
- Marcadores biológicos de necrosis miocárdicaRevista Espanola de Cardiologia, 2003
- Anthracycline-induced cardiotoxicity in children and young adultsCritical Reviews in Oncology/Hematology, 1998
- Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood CancerNew England Journal of Medicine, 1995
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991